Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Daily News

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

Shelley Wood

July 15, 2022

News Conference News ACC 2022

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

Todd Neale

April 06, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Conference News ACC 2022

Pericardial Effusion Signals Worse Prognosis in COVID-19 Inpatients

Todd Neale

March 29, 2022

News Daily News

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Michael O'Riordan

March 21, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Advertisement

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

FLASH: More Data to Support Mechanical Thrombectomy in PE

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Pericardial Effusion Signals Worse Prognosis in COVID-19 Inpatients

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Modified Surgical MV Repair Stands Up to Replacement

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content